Key result
Depletion of Valosin-Containing Protein (VCP) significantly inhibited coronavirus replication by preventing the degradation of the nucleocapsid N protein and causing virus accumulation in early endosomes.
Identifies valosin-containing protein (VCP/p97) as a critical host factor for coronavirus exit from early endosomes, providing a potential target for antiviral therapeutics.
VCP may represent a host-directed antiviral target in animal models; leaves open translation to human coronavirus therapy.
UNLABELLED: Coronaviruses are RNA viruses with a large zoonotic reservoir and propensity for host switching, representing a real threat for public health, as evidenced by severe acute respiratory syndrome (SARS) and the emerging Middle East respiratory syndrome (MERS). Cellular factors required for their replication are poorly understood. Using genome-wide small interfering RNA (siRNA) screening, we identified 83 novel genes supporting infectious bronchitis virus (IBV) replication in human cells. Thirty of these hits can be placed in a network of interactions with viral proteins and are involved in RNA splicing, membrane trafficking, and ubiquitin conjugation. In addition, our screen reveals an unexpected role for valosin-containing protein (VCP/p97) in early steps of infection. Loss of VCP inhibits a previously uncharacterized degradation of the nucleocapsid N protein. This inhibition derives from virus accumulation in early endosomes, suggesting a role for VCP in the maturation of virus-loaded endosomes. The several host factors identified in this study may provide avenues for targeted therapeutics. IMPORTANCE: Coronaviruses are RNA viruses representing a real threat for public health, as evidenced by SARS and the emerging MERS. However, cellular factors required for their replication are poorly understood. Using genome-wide siRNA screening, we identified novel genes supporting infectious bronchitis virus (IBV) replication in human cells. The several host factors identified in this study may provide directions for future research on targeted therapeutics.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2015) studied Coronavirus infection. siRNA knockdown of Valosin-Containing Protein (VCP) vs. Nontargeting siRNA control was evaluated on Viral replication (luciferase activity, viral RNA, viral titer). Depletion of Valosin-Containing Protein (VCP) significantly inhibited coronavirus replication by preventing the degradation of the nucleocapsid N protein and causing virus accumulation in early endosomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: